-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Enanta Pharmaceuticals Inc quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2011 to 2023.
- Enanta Pharmaceuticals Inc Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$395K, a 109% decline year-over-year.
- Enanta Pharmaceuticals Inc Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was -$2.79M, a 165% decline year-over-year.
- Enanta Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2023 was $2.82M.
- Enanta Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2022 was -$433K, a 98.5% increase from 2021.
- Enanta Pharmaceuticals Inc annual Income Tax Expense (Benefit) for 2021 was -$28.6M, a 2588% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)